The landscape of chronic illness treatment is shifting as researchers move beyond mere symptom management toward addressing the biological roots of exhaustion. As we move through 2026, a clear trend has emerged: rapamycin, once known primarily as a transplant drug and longevity "miracle," is being repurposed as a precision tool for patients battling Long COVID…

Rapamycin is the strongest drug candidate in longevity research so far, but it is not yet a proven “true anti-aging drug” in humans. The evidence is compelling in animals and promising in early human studies, yet we still lack the kind of large, long-term trials needed to say it reliably slows human aging. Rapamycin sits…

People are tracking the latest breakthroughs in clinical longevity, already know that rapamycin has shifted from a niche immunosuppressant to the most heavily debated molecule in geroscience. But exactly why would a doctor prescribe rapamycin today? For decades, the FDA has approved rapamycin (known generically as sirolimus) specifically to prevent organ transplant rejection and treat…